サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1747883

医薬品・栄養補助食品添加物の世界市場

Pharmaceutical and Nutraceutical Additives

出版日
ページ情報
英文 189 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.06円
医薬品・栄養補助食品添加物の世界市場
出版日: 2025年06月13日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品・栄養補助食品添加物の世界市場は2030年までに369億米ドルに達する見込み

2024年に282億米ドルと推定される医薬品・栄養補助食品添加物の世界市場は、2024年から2030年にかけてCAGR 4.6%で成長し、2030年には369億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるカプセルの形態は、CAGR 4.6%を記録し、分析期間終了時には156億米ドルに達すると予測されます。錠剤セグメントの成長率は、分析期間中CAGR 5.5%と推定されます。

米国市場は77億米ドルと推定、中国はCAGR 8.3％で成長予測

米国の医薬品・栄養補助食品添加物市場は、2024年に77億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに76億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.9%と3.6%と予測されています。欧州では、ドイツがCAGR 2.7%で成長すると予測されています。

世界の医薬品・栄養補助食品添加物市場- 主要動向と促進要因のまとめ

医薬品・栄養補助食品製剤において添加物が戦略的に重要性を増しているのはなぜか？

添加物は、医薬品と栄養補助食品の安定性、生物学的利用能、嗜好性、製造可能性において重要な役割を果たします。結合剤、コーティング剤、崩壊剤、乳化剤、安定剤から香味剤、保存料に至るまで、これらの補助物質は、製品のライフサイクルを通じて有効成分の有効性、安全性、患者への優しさを維持するために不可欠です。便利で多機能な剤形に対する消費者の需要が高まるにつれ、錠剤、カプセル剤、粉末剤、シロップ剤、機能性食品など、特殊な添加物の使用が拡大しています。

予防ヘルスケアに対する消費者の関心に後押しされた医薬品業界と栄養補助食品業界の融合も、製剤設計の複雑さを増しています。製品が個別化された健康、複数の化合物のブレンド、薬剤と栄養素のハイブリッド配合へとシフトするにつれ、添加物は溶解性の改善、放出プロファイルの制御、味のマスキング、生物活性化合物の安定化などに使用されるようになっています。このため、治療とウェルネスの両方の用途に合わせた、高純度で多機能、規制に準拠した賦形剤に対する強い需要が生まれています。

クリーンラベルへの期待、規制遵守、機能性革新はどのように市場を形成しているか？

クリーンラベルや植物由来の健康食品の台頭は、添加物の選択に大きな影響を与えています。消費者はますます成分表を吟味するようになり、メーカーは人工着色料、合成保存料、アレルゲンを排除するよう求められています。このシフトは、安定剤や増粘剤としてアカシアガム、米デンプン、セルロース誘導体などの天然代替物の採用を促しています。栄養補助食品の分野では、透明性と消費者の信頼を維持するために、ハーブエキス担体、ペクチンベースのゲル化剤、食品グレードの乳化剤が好ましい選択肢になりつつあります。

規制面では、添加物サプライヤーはUSP-NF、Ph.Eur.、FDAのGRAS指定など、厳格な薬局方基準や国際ガイドラインを遵守しなければならないです。このため、バッチ間の一貫性を確保するためのトレーサビリティ・システム、クリーンルームでの製造、分析バリデーションへの投資が推進されています。さらに、マイクロカプセル化、共加工賦形剤、リポソーム送達システムなどの技術革新により、デリケートな栄養素や原薬をより効果的に保護し、放出制御することが可能になり、有効性と保存安定性が向上しています。

個別化栄養、用法用量の革新、地域的な食生活のシフトが添加剤需要を拡大させているのはなぜか？

個別化医療と精密栄養学は、チュアブル、グミ、ソフトジェルから口腔内崩壊フィルムや時間放出錠に至るまで、カスタマイズされた剤形をサポートする添加物の開発に拍車をかけています。低圧縮結合剤、改質デンプン、pH感応性コーティング剤などの添加剤は、こうしたデリバリーイノベーションを可能にする重要な要素であり、特に小児や老人の間で、患者に合わせた吸収とアドヒアランスの向上を可能にしています。

一方、ラクトースフリー、グルテンフリー、コーシャ／ハラール認証製剤に対する地域的嗜好が、ブランド各社に文化的に敏感な添加物の調達を促しています。アジア太平洋とラテンアメリカでは栄養補助食品市場が活況を呈しており、現地の食習慣や漢方薬の伝統に沿った生物機能性賦形剤の需要が特に高まっています。土着の植物源に由来する天然甘味料、風味増強剤、生物学的利用能増強剤は、急速に成長する健康志向の人口に対応するため、添加物戦略に取り入れられています。

医薬品・栄養補助食品添加物市場の世界的成長の原動力は？

医薬品・栄養補助食品添加物市場の成長は、新規剤形に対する需要の高まり、クリーンラベル賦形剤の開発、予防医療や統合医療に対する世界の関心の高まりなど、いくつかの要因によって牽引されています。主な成長要因は、医薬品グレードの精度と栄養補助食品の消費者への訴求力の融合が拡大していることであり、安全で機能的かつ柔軟な添加剤ソリューションが必要とされています。

バイオアベイラビリティの最適化、規制の調和、送達システムの革新における研究開発の増加に伴い、添加物はもはや不活性成分としてではなく、治療効果と消費者の満足度を高める戦略的イネーブラーとして捉えられています。高齢化、セルフケアの動向、個別化された健康が世界的に拡大する中、安全で効果的な、市場に即応した健康製品の開発における添加物の役割は、今後も大きく成長し続けると思われます。

セグメント

形態（カプセル、錠剤、液体、粉末、その他の形態）

調査対象企業の例（注目の合計42社）

  • Akums Drugs and Pharmaceuticals
  • Alkem Laboratories
  • Amway
  • Archer Daniels Midland Company
  • BASF SE
  • Bayer AG
  • Cargill, Incorporated
  • Catalent, Inc.
  • Danone S.A.
  • Divi's Laboratories Limited
  • Herbalife Nutrition Ltd.
  • Ingredion Incorporated
  • International Flavors & Fragrances
  • Kerry Group plc
  • Nestle Health Science
  • NOW Foods
  • Roquette Freres
  • Sensient Technologies Corporation
  • Tischon Corporation
  • Vivimed Labs Limited

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP35513

Global Pharmaceutical and Nutraceutical Additives Market to Reach US$36.9 Billion by 2030

The global market for Pharmaceutical and Nutraceutical Additives estimated at US$28.2 Billion in the year 2024, is expected to reach US$36.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Capsule Form, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$15.6 Billion by the end of the analysis period. Growth in the Tablets Form segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.7 Billion While China is Forecast to Grow at 8.3% CAGR

The Pharmaceutical and Nutraceutical Additives market in the U.S. is estimated at US$7.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Pharmaceutical and Nutraceutical Additives Market - Key Trends & Drivers Summarized

Why Are Additives Gaining Strategic Importance in Pharma and Nutraceutical Formulations?

Additives play a critical role in the stability, bioavailability, palatability, and manufacturability of both pharmaceutical and nutraceutical products. These auxiliary substances-ranging from binders, coatings, disintegrants, emulsifiers, and stabilizers to flavoring agents and preservatives-are vital for ensuring that active ingredients remain effective, safe, and patient-friendly throughout the product’s lifecycle. With rising consumer demand for convenient and multi-functional dosage forms, the use of specialized additives is expanding across tablets, capsules, powders, syrups, and functional foods.

The convergence of pharmaceutical and nutraceutical industries-driven by consumer interest in preventive healthcare-is also increasing the complexity of formulation design. As products shift toward personalized health, multi-compound blends, and hybrid drug-nutrient combinations, additives are being used to improve solubility, control release profiles, mask taste, and stabilize bioactive compounds. This is creating a strong demand for high-purity, multifunctional, and regulatory-compliant excipients tailored for both therapeutic and wellness applications.

How Are Clean Label Expectations, Regulatory Compliance, and Functional Innovations Shaping the Market?

The rise of clean-label and plant-based health products is significantly influencing additive selection. Consumers increasingly scrutinize ingredient lists, pushing manufacturers to eliminate artificial colors, synthetic preservatives, and allergens. This shift is prompting the adoption of natural alternatives such as acacia gum, rice starch, and cellulose derivatives as stabilizers and thickeners. In the nutraceutical space, herbal extract carriers, pectin-based gelling agents, and food-grade emulsifiers are becoming preferred choices to maintain transparency and consumer trust.

On the regulatory front, additive suppliers must adhere to strict pharmacopeial standards and international guidelines such as USP-NF, Ph. Eur., and FDA GRAS designations. This is driving investments in traceability systems, cleanroom manufacturing, and analytical validation to ensure batch-to-batch consistency. Moreover, innovation in microencapsulation, co-processed excipients, and liposomal delivery systems is enabling more effective protection and controlled release of sensitive nutrients and APIs-thus improving efficacy and shelf stability.

Why Are Personalized Nutrition, Dosage Innovation, and Regional Dietary Shifts Expanding Additive Demand?

Personalized medicine and precision nutrition are catalyzing the development of additives that support customized dosage forms-ranging from chewables, gummies, and soft gels to orally disintegrating films and time-release tablets. Additives such as low-compression binders, modified starches, and pH-sensitive coatings are key enablers of these delivery innovations, allowing for tailored absorption and improved patient adherence, especially among pediatric and geriatric populations.

Meanwhile, regional preferences for lactose-free, gluten-free, or kosher/halal-certified formulations are pushing brands to source culturally sensitive additives. The booming nutraceutical market in Asia-Pacific and Latin America is particularly driving demand for biofunctional excipients that align with local dietary habits and herbal medicine traditions. Natural sweeteners, flavor enhancers, and bioavailability enhancers derived from indigenous plant sources are being incorporated into additive strategies to cater to these rapidly growing health-conscious populations.

What’s Driving the Global Growth of the Pharmaceutical and Nutraceutical Additives Market?

The growth in the pharmaceutical and nutraceutical additives market is driven by several factors including the rising demand for novel dosage forms, clean-label excipient development, and the growing global interest in preventive and integrative health. A major growth driver is the expanding convergence between pharmaceutical-grade precision and nutraceutical consumer appeal-necessitating safe, functional, and flexible additive solutions.

With increasing R&D in bioavailability optimization, regulatory harmonization, and delivery system innovation, additives are no longer viewed as inert ingredients but as strategic enablers of therapeutic efficacy and consumer satisfaction. As aging demographics, self-care trends, and personalized wellness expand worldwide, the role of additives in creating safe, effective, and market-ready health products will continue to grow significantly.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical and Nutraceutical Additives market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Capsule, Tablets, Liquid, Powder, Other Forms)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Akums Drugs and Pharmaceuticals
  • Alkem Laboratories
  • Amway
  • Archer Daniels Midland Company
  • BASF SE
  • Bayer AG
  • Cargill, Incorporated
  • Catalent, Inc.
  • Danone S.A.
  • Divi's Laboratories Limited
  • Herbalife Nutrition Ltd.
  • Ingredion Incorporated
  • International Flavors & Fragrances
  • Kerry Group plc
  • Nestle Health Science
  • NOW Foods
  • Roquette Freres
  • Sensient Technologies Corporation
  • Tischon Corporation
  • Vivimed Labs Limited

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Pharmaceutical and Nutraceutical Additives - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Functional Health Products Drives Growth in Nutraceutical Additive Innovation
    • Expansion of Clean Label and Bioavailable Additive Portfolios Throws the Spotlight on Natural Compound Enhancers
    • OEM Innovation in Microencapsulation and Controlled-Release Additives Enhances Therapeutic Efficacy
    • Growth in Preventive Healthcare and Wellness Supplementation Spurs Additive Use in Daily Nutrition Formulations
    • OEM Collaboration With Formulators and CROs Accelerates Custom Additive Solutions for OTC and Rx Products
    • Surge in Demand for Digestive Health, Immunity, and Cognitive Support Supports Specialized Additive Inclusion
    • OEM Focus on Non-GMO, Allergen-Free, and Kosher/Halal Certified Additives Enhances Global Marketability
    • Growth in Sports Nutrition and Functional Beverages Drives Need for Stability and Solubility Enhancers
    • OEM Development of Bioenhancers and Absorption Boosters Expands Oral Supplement Efficiency
    • Rising Regulatory Scrutiny on Excipient Purity Spurs Innovation in Pharmaceutical-Grade Additive Sourcing
    • OEM Entry Into Prebiotic, Polyphenol, and Botanical Additives Supports Natural Formulation Trends
    • Expansion of Fortified Snacks and Gummy Supplements Boosts Additive Compatibility Requirements
    • OEM Investment in Fermentation-Derived and Postbiotic Additives Strengthens Gut-Brain Axis Applications
    • Growth in Personalized Nutrition Platforms Spurs Demand for Customizable Additive Blends
    • OEM Advances in Solubility and Particle Size Reduction Techniques Improve Bioavailability Across Forms
    • Increasing Use of Additive Blends in Medical Foods and Clinical Nutrition Expands Therapeutic Value
    • OEM Differentiation Through Human Clinical Trials and Mechanism of Action Research Enhances Efficacy Claims
    • Rise in Functional Pet Supplements and Veterinary Nutrition Fuels Cross-Over Additive Development
    • OEM Participation in Sustainable Sourcing and Green Chemistry for Additives Strengthens ESG Profile
    • Global Market Diversification in Infant, Senior, and Women's Health Supplements Expands Additive Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pharmaceutical and Nutraceutical Additives Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pharmaceutical and Nutraceutical Additives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Capsule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Capsule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Capsule by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Powder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • JAPAN
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • CHINA
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • EUROPE
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Pharmaceutical and Nutraceutical Additives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • FRANCE
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • GERMANY
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Spain 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Russia 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of Europe 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Pharmaceutical and Nutraceutical Additives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Australia 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • INDIA
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: India 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: South Korea 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Pharmaceutical and Nutraceutical Additives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Argentina 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Brazil 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Mexico 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Latin America 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Pharmaceutical and Nutraceutical Additives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Iran 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Israel 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Saudi Arabia 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UAE 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Middle East 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030
  • AFRICA
    • Pharmaceutical and Nutraceutical Additives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Pharmaceutical and Nutraceutical Additives by Form - Capsule, Tablets, Liquid, Powder and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Africa 15-Year Perspective for Pharmaceutical and Nutraceutical Additives by Form - Percentage Breakdown of Value Sales for Capsule, Tablets, Liquid, Powder and Other Forms for the Years 2015, 2025 & 2030

IV. COMPETITION